Brief: Generation Bio Presents Data Demonstrating First Lipid Nanoparticle To Achieve Uniform Retinal Transduction And Tolerability
Oct 22 (Reuters) - Generation Bio Co GBIO.O :
* GENERATION BIO PRESENTS DATA DEMONSTRATING FIRST LIPID
NANOPARTICLE TO ACHIEVE UNIFORM RETINAL TRANSDUCTION AND
TOLERABILITY VIA SUB-RETINAL DELIVERY OF CEDNA AND MRNA AT THE
EUROPEAN SOCIETY OF GENE AND CELL THERAPY 2021 ANNUAL VIRTUAL
CONGRESS
* GENERATION BIO CO - UNIFORM RETINAL TRANSDUCTION AND
TOLERABILITY ALSO DEMONSTRATED FOR CTLNP DELIVERY OF MRNA
Source text for Eikon: ID:nGNX2FvRKN
Further company coverage: GBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Generation Bio
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Nodthera Appoints Geoff Mcdonough, M.D., As Independent Board Member